Reducing HIV treatment interruptions in Malawi
Part of Infections clinical trials.
This study tests a program to help people in Malawi stay on their HIV treatment even when they travel or move around. Researchers want to know if extra support can prevent gaps in care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years old or older
- You are living with HIV
- You are either starting HIV treatment for the first time or returning to care after missing a refill by more than 28 days
- You are not at the clinic just for an emergency refill or a routine refill with no recent gap in care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people living with HIV who have missed their recent treatment appointment get back on track. It aims to find better ways to support ongoing treatment.
This study gathers information from people receiving HIV care in Malawi to better understand and improve HIV treatment. You may be included if you are an adult or older and you are currently accessing HIV care during the study’s time period.
This study is testing a program to help people with HIV stick with their medication. It looks at how well doctors and patients work together to make treatment decisions and improve health outcomes.
This study looks for HIV drug resistance in people who have been on a specific first-line HIV medication (TLD) for at least 6 months and still have detectable virus. It aims to understand if resistance is developing so that better treatments can be planned.
This Phase 2 study uses special scans (PET/CT) and tissue sampling (biopsy) to learn what is happening in the body while people with HIV take a planned break from antiretroviral therapy (ART) for up to 90 days. It may help researchers find better ways to control HIV without ongoing treatment, though joining involves careful monitoring during the pause.
This trial tests whether a combination of powerful antibodies (bNAbs) can help control HIV after stopping standard HIV treatment. Participants will pause their daily HIV medications while receiving these antibodies, and doctors will closely monitor their immune system and virus levels. It's for people who are already well-controlled on HIV treatment and have participated in a specific earlier study.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.